Abstract
A rapid, blood-based triage test that allows targeted investigation for tuberculosis at the point of care could shorten the time to tuberculosis treatment and reduce mortality. We aimed to test the performance of a host blood transcriptomic signature (RISK11) in diagnosing tuberculosis and predicting progression to active pulmonary disease (prognosis) in people with HIV in a community setting.
Key Data
-
Publication Date01 June 2021
-
Primary AuthorSimon C Mendelsohn
-
SourceThe Lancet
-
LanguageEnglish
Click below to visit original source: